Lipid-lowering therapy stabilizes plaque, reduces events by limiting inflammation.
Libby
Peter
P
D002097:C-Reactive Protein / Q000378:metabolism; D003327:Coronary Disease / Q000188:drug therapy*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007249:Inflammation / Q000188:drug therapy*; D014481:United States
D000960:Hypolipidemic Agents; D002097:C-Reactive Protein